Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 229 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-03-01 | 2024-03-15 | 221093 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-01 | 2024-03-22 | 221096 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2024-03-01 | 2024-03-15 | 221099 |
| APO-KETOROLAC | 10MG | TABLET | Resolved | 2024-03-01 | 2024-04-19 | 221102 |
| APO-DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221678 |
| MYA | 0.02MG 3.00MG | TABLET | Resolved | 2024-03-08 | 2024-03-15 | 221690 |
| APO-BACLOFEN | 10MG | TABLET | Actual shortage | 2024-03-08 | 2024-05-17 | 221696 |
| APO-ELTROMBOPAG | 50MG | TABLET | Resolved | 2024-03-08 | 2024-04-05 | 221699 |
| APO TRIAZIDE | 25MG 50MG | TABLET | Resolved | 2024-03-08 | 2024-04-05 | 221702 |
| APO-TADALAFIL | 5MG | TABLET | Resolved | 2024-03-08 | 2024-05-03 | 221705 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2024-03-08 | 2024-03-15 | 221708 |
| APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-08 | 2024-03-15 | 221717 |
| APO-CLARITHROMYCIN | 250MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221720 |
| APO-METHYLPHENIDATE | 5MG | TABLET | Resolved | 2024-03-08 | 2024-05-10 | 221723 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221726 |
| APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2024-03-08 | 2024-05-10 | 221729 |
| APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221732 |
| APO-DOXY CAP 100MG | 100MG | CAPSULE | Resolved | 2024-03-15 | 2024-04-05 | 222414 |
| APO-BACLOFEN | 20MG | TABLET | Actual shortage | 2024-03-15 | 2024-05-17 | 222455 |
| APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2024-03-15 | 2024-04-05 | 222458 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
| APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
| APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
| APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |